161 related articles for article (PubMed ID: 36183012)
1. Survey of perspectives of people with inherited retinal diseases on ocular gene therapy in Australia.
Mack HG; Britten-Jones AC; McGuinness MB; Chen FK; Grigg JR; Jamieson RV; Edwards TL; De Roach J; O'Hare F; Martin KR; Ayton LN
Gene Ther; 2023 Apr; 30(3-4):336-346. PubMed ID: 36183012
[TBL] [Abstract][Full Text] [Related]
2. A multinational survey of potential participant perspectives on ocular gene therapy.
Britten-Jones AC; McGuinness MB; Chen FK; Grigg JR; Mack HG; Ayton LN
Gene Ther; 2024 May; 31(5-6):314-323. PubMed ID: 38565634
[TBL] [Abstract][Full Text] [Related]
3. Measurement Properties of the Attitudes to Gene Therapy for the Eye (AGT-Eye) Instrument for People With Inherited Retinal Diseases.
McGuinness MB; Britten-Jones AC; Ayton LN; Finger RP; Chen FK; Grigg J; Mack HG
Transl Vis Sci Technol; 2022 Feb; 11(2):14. PubMed ID: 35133402
[TBL] [Abstract][Full Text] [Related]
4. Perspectives of people with inherited retinal diseases on ocular gene therapy in Australia: protocol for a national survey.
Mack HG; Chen FK; Grigg J; Jamieson R; De Roach J; O'Hare F; Britten-Jones AC; McGuinness M; Tindill N; Ayton L;
BMJ Open; 2021 Jun; 11(6):e048361. PubMed ID: 34158306
[TBL] [Abstract][Full Text] [Related]
5. Patient-Reported Health-Related Quality of Life in Individuals with Inherited Retinal Diseases.
Schofield D; Kraindler J; Tan O; Shrestha R; Jelovic D; West S; Ma A; Grigg J; Jamieson RV
Ophthalmol Sci; 2022 Mar; 2(1):100106. PubMed ID: 36246188
[TBL] [Abstract][Full Text] [Related]
6. Estimation of impact of
Lloyd A; Piglowska N; Ciulla T; Pitluck S; Johnson S; Buessing M; O'Connell T
Br J Ophthalmol; 2019 Nov; 103(11):1610-1614. PubMed ID: 30658988
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J
Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755
[TBL] [Abstract][Full Text] [Related]
8. Patient experiences and perceived value of genetic testing in inherited retinal diseases: a cross-sectional survey.
Britten-Jones AC; Schultz J; Mack HG; Kearns LS; Huq AJ; Ruddle JB; Mackey DA; Hewitt AW; Edwards TL; Ayton LN
Sci Rep; 2024 Mar; 14(1):5403. PubMed ID: 38443430
[TBL] [Abstract][Full Text] [Related]
9. Patient-reported burden and overall impact of dry eye disease across eight European countries: a cross-sectional web-based survey.
Boboridis KG; Messmer EM; Benítez-Del-Castillo J; Meunier J; Sloesen B; O'Brien P; Quadrado MJ; Rolando M; Labetoulle M
BMJ Open; 2023 Mar; 13(3):e067007. PubMed ID: 36931668
[TBL] [Abstract][Full Text] [Related]
10. Construct Validity of Inherited Retinal Disease-Specific Patient-Reported Outcome Measures.
Jayasundera KT; Abuzaitoun RO; Popova L; Abalem MF; Andrews CA; Lacy GD; Fresco DM; Musch DC
Am J Ophthalmol; 2023 Apr; 248():116-126. PubMed ID: 36470512
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with vision-related quality of life among the adult population living in Nagorno Karabagh.
Harutyunyan T; Giloyan A; Petrosyan V
Public Health; 2017 Dec; 153():137-146. PubMed ID: 29049920
[TBL] [Abstract][Full Text] [Related]
12. The National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) Project.
Clemons TE; Gillies MC; Chew EY; Bird AC; Peto T; Figueroa M; Harrington MW;
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4340-6. PubMed ID: 18586874
[TBL] [Abstract][Full Text] [Related]
13. Patient-reported burden of dry eye disease in the UK: a cross-sectional web-based survey.
Hossain P; Siffel C; Joseph C; Meunier J; Markowitz JT; Dana R
BMJ Open; 2021 Mar; 11(3):e039209. PubMed ID: 33664064
[TBL] [Abstract][Full Text] [Related]
14. Patient-Reported Burden of Dry Eye Disease in the United States: Results of an Online Cross-Sectional Survey.
Dana R; Meunier J; Markowitz JT; Joseph C; Siffel C
Am J Ophthalmol; 2020 Aug; 216():7-17. PubMed ID: 32277941
[TBL] [Abstract][Full Text] [Related]
15. Current Management of Inherited Retinal Degeneration Patients in Europe: Results of a Multinational Survey by the European Vision Institute Clinical Research Network.
Lorenz B; Tavares J; van den Born LI; Marques JP; Scholl HPN;
Ophthalmic Res; 2021; 64(4):622-638. PubMed ID: 33465765
[TBL] [Abstract][Full Text] [Related]
16. Responsiveness of Vision-Specific and General Quality of Life Metrics to Ocular and Systemic Events in Patients with Uveitis.
Sugar EA; Burke AE; Venugopal V; Thorne JE; Holbrook JT;
Ophthalmology; 2020 Dec; 127(12):1710-1718. PubMed ID: 32717341
[TBL] [Abstract][Full Text] [Related]
17. Mapping the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) to EQ-5D utility scores.
Kay S; Ferreira A
Ophthalmic Epidemiol; 2014 Apr; 21(2):66-78. PubMed ID: 24568628
[TBL] [Abstract][Full Text] [Related]
18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
19. [Vision-and health-related quality of life in patients with uveitis].
Zhang J; Yan HG; Chi Y; Guo CY; Yang L
Zhonghua Yan Ke Za Zhi; 2016 Jun; 52(6):429-36. PubMed ID: 27373571
[TBL] [Abstract][Full Text] [Related]
20. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
